T1	Participants 643 759	837 Kenyan orphan youth in grades 7 and 8 enrolled in an HIV prevention clinical trial with HSV-2 biomarker outcomes
T2	Participants 1061 1142	28 adolescents (3.3%) were identified as HSV-2 seropositive, six as indeterminate
T3	Participants 1154 1227	22 positive and all indeterminates were WB tested; 20 and 5, respectively
